According to TechFlow, on November 19, Bloomberg reported that Chinese AI biotech company MegaRobo Technologies has completed a financing round of nearly $200 million, with investors including the Oman Investment Fund.
In a statement, MegaRobo noted that CCB International, along with existing investors Asia Investment Capital, Granite Asia, and Innovation Works, also participated in this round of funding. The proceeds will be used for research and development and global expansion.





